(Q34794660)

English

Algorithm for the early diagnosis and treatment of patients with cross reactive immunologic material-negative classic infantile pompe disease: a step towards improving the efficacy of ERT.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Algorithm for the early diagnosis and treatment of patients with cross reactive immunologic material-negative classic infantile pompe disease: a step towards improving the efficacy of ERT. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Priya S Kishnani

16

object named as

Priya S Kishnani

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Suhrad G Banugaria

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sean N Prater

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Trusha T Patel

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Stephanie M Dearmey

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Christie Milleson

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Kathryn B Sheets

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Deeksha S Bali

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Catherine W Rehder

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Julian A J Raiman

9

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Raymond A Wang

10

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Francois Labarthe

11

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Joel Charrow

12

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Paul Harmatz

13

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Pranesh Chakraborty

14

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Amy S Rosenberg

15

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

0 references

publication date

25 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

e67052

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

copyright license

Creative Commons CC0 License

25 June 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

The emerging phenotype of long-term survivors with infantile Pompe disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

Persistence of high sustained antibodies to enzyme replacement therapy despite extensive immunomodulatory therapy in an infant with Pompe disease: need for agents to target antibody-secreting plasma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

Atypical immunologic response in a patient with CRIM-negative Pompe disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

Rituximab resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

Pompe disease in infants: improving the prognosis by newborn screening and early treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

Immunomodulation with intravenous immunoglobulin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3692419

8 July 2018

Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0067052

21 January 2018

Elimination of antibodies to recombinant enzyme in Pompe's disease.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0067052

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0067052

21 January 2018

CRIM-negative infantile Pompe disease: 42-month treatment outcome.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0067052

21 January 2018

Severely impaired health status at diagnosis of Pompe disease: a cross-sectional analysis to explore the potential utility of neonatal screening.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0067052

21 January 2018

Immune modulation in Pompe disease treated with enzyme replacement therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23825616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23825616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expanding newborn screening: process, policy, and priorities

1 reference

https://pubmed.ncbi.nlm.nih.gov/23825616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0067052

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

2013PLoSO...867052B

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34794660&oldid=1864534962"